Discussion
Otalgia can be classified as primary (otogenic, originating from pathologies inside the ear) or referred (nonotogenic, originating from outside the ear). A negative otologic exam and otalgia can be related to various diseases because the ear has a rich nerve supply from many cranial (V, VII, IX, and X) and cervical (C2 and C3). Referred otalgia often poses a difficult diagnostic challenge to otolaryngologists.
The term "bruxism" originates from the Greek word brychein, which means to grind. Bruxism is generally defined as non-functional jaw movement characterized by the involuntary grinding and/or clenching of the teeth. It is thought to be an important etiological factor of abnormal tooth wear and periodontal disease. This disorder can also trigger headaches, TMDs, and pain in the masticatory muscles [
4]. The prevalence of bruxism has not been well defined (ranging from 6-95% in previous studies) because of differences in the methods and criteria for evaluating bruxism [5].
The etiology of bruxism remains unclear despite the proposal of numerous theories. While it is evident that bruxism can destructively affect the oral structures and masticatory system, it is difficult to understand the condition and its associated activity clinically.
Bruxism can occur during wakefulness or sleep. The American Academy of Sleeping Disorders proposed the terms Awake and Sleep Bruxism. Bruxism during periods of wakefulness is 'Awake bruxism' (AB), otherwise termed diurnal bruxism. AB is usually seen as a jaw clenching habit that appears in response to stress and anxiety [
6]. On the other hand, bruxism during sleep, whether during the daytime or night, is termed 'Sleep bruxism' (SB), also known as nocturnal tooth grinding. SB is a sleep related rhythmic masticatory activity generally associated with periods of arousal [
7]. Both AB and SB are sub-classified as either primary, not related to any other medical condition, or secondary, associated with neurological disorders or an adverse side effect of drugs.
Bruxism can lead to dental wear, jaw muscle pain and fatigue, and temporal headaches. In some severe forms it can compromise oral functions such as chewing, speaking, and swallowing [
8]. This is a predisposing and exacerbating factor of TMDs, which are a common cause of referred otalgia [
3]. The most common otologic symptoms related to TMDs are otalgia, tinnitus, and vertigo [
9].
Referred otalgia secondary to TMDs can be explained by the closely connected sensory innervation of the oral cavity, oropharynx, and ear, which are derived from the same embryological origins [
10]. The ear is innervated by many nerves, including the fifth, seventh, ninth, and tenth cranial nerves, as well as superficial sensory branches from the cervical plexus. Similarly, the temporomandibular joint is innervated by the auriculotemporal branch of the fifth and seventh cranial nerves. The otologic symptoms that are commonly associated with TMDs, such as tinnitus, otalgia, dizziness, and/or vertigo, are also the most commonly observable effects of bruxism [
11]. These otologic symptoms are known to be improved by dental treatment and therefore it is important to differentiate between primary otologic symptoms and those caused by bruxism.
In real clinical practice, TMDs are sometimes misdiagnosed as tension headaches or migraine because of the nature of the headache. Otolaryngologists and neurologists can easily overlook these disorders and conduct unnecessary and expensive investigations. In the present case, the patient presented with intermittent and intractable right otalgia frequently radiating to the ipsilateral temporal area. She had been taking a migraine-specific medication and other analgesic drugs. In cases such as this, the patient may pay multiple visits to otorhinolaryngology, neurology, and pain management clinics, where the examinations reveal normal findings.
The treatments for bruxism include intraoral appliances, medications, behavioral modification techniques, and injections of botulinum toxin in the masticatory muscles.
The use of an occlusal splint is considered a conservative and reversible therapy for patients with TMDs and/or bruxism to prevent tooth attrition and overload of the temporomandibular joint structures and masticatory muscles [
12]. In general, the design of the device is simple, it covers the whole maxillary or mandibular dental arch, and is well tolerated by patients. In the present case, the patient showed severe wear on the anterior teeth. Additionally, the nocturnal occlusal force generated during the sleep-associated bruxism was so strong that the occlusal splint was frequently fractured. She was asked to use the occlusal splint continuously, in order to protect her teeth even while asleep.
Intramuscular injections with BTX are used in the treatment of the movement disorders associated with increased muscle tone, such as spasticity and dystonia, and the autonomic disorders associated with cholinergic overactivity and hyperhidrosis. Because of its muscle-relaxing and possible analgesic effects, BTX has also gained much interest as a possible treatment for myofascial pain and headache disorders [
13]. Many studies have reported that BTX injections are effective for controlling AB. Other studies with only SB patients showed that BTX injections can reduce the frequency of jaw motor events [
14], decrease bruxism-induced pain levels, and are equally effective as oral splints for alleviating pain [
15]. The bulky region of the masseter and temporalis muscles has been regarded as an effective point for BTX injections, as it is the richest arborized area of the perforating nerve branches. The effects of a single BTX injection on the masticatory force are known to last from 2 weeks to up to 24 weeks, but start to decline 4 weeks after injection. In the present case, the patient received monthly repeated BTX-A injections over 4 months in the masseter and anterior temporalis muscles bilaterally in order to reduce the sustained force between the opposing teeth.
No studies have been published on the relationship between good sleep hygiene and the extent of SB. However, SB is known to occur mainly in the lighter sleep stages, or 'rapid eye movement sleep'. Avoiding stimulants such as tea, coffee, alcohol, and cigarettes for several hours before bed and maintaining a regular sleep schedule promotes better sleep. Better sleep means that more time is spent in the deeper sleep stages, also known as 'slow wave sleep', and fewer periods of arousal occur.
After the treatment with the occlusal splint and BTX injections, along with good sleep hygiene, the symptoms of this patient were alleviated. Therefore, cooperation between ENT clinicians and dentists is required for the diagnosis and treatment of bruxism and the consequential referred otalgia.
In conclusion, the author recommends that ENT clinicians perform a rapid and simple dental examination in cases of a negative otologic exam and otalgia. The early diagnosis of bruxism is possible if ENT clinicians pay attention to the typical features: worn incisal edges, flattened occlusal surfaces of the molar teeth, scalloping of the lateral borders of the tongue, ridging of the buccal mucosa at the occlusal line, and masseter muscle hypertrophy. This practice will reduce the risk of misdiagnosis with other neurological causes such as migraine, and facilitate the timely and accurate diagnosis of referred otalgia secondary to bruxism.
In conclusion, referred otalgia secondary to bruxism can be a diagnostic challenge for otolaryngologists. Although the management of these disorders has traditionally fallen under the purview of dentists, the most common symptoms are otologic problems. Therefore, for patients presenting with a negative otologic exam and persistent otalgia, careful attention should be paid to their dental status, because of the potential of bruxism-induced otalgia. This would require multidisciplinary cooperation between ENT clinicians and dentists. The author determined that otalgia originating from bruxism deserves careful attention, along with the consideration of dental treatment, which will be helpful in eliminating bruxism-induced otalgia.